The exposure to the IPF-SN also elevated ITGA5 levels, the fibronectin receptor, in addition to NFκB pathway activation (pIκBα↑ 150%, p < 0.05). The gene discussed is ITGA5; the disease is idiopathic pulmonary fibrosis.